[HTML][HTML] Effects of antioxidants in human milk on bronchopulmonary dysplasia prevention and treatment: A review

X Yang, S Jiang, X Deng, Z Luo, A Chen, R Yu - Frontiers in nutrition, 2022 - frontiersin.org
Bronchopulmonary dysplasia (BPD) is a severe chronic lung illness that affects neonates,
particularly premature infants. It has far-reaching consequences for infant health and their …

[HTML][HTML] The role of sirtuin-1 in immune response and systemic lupus erythematosus

Y Qiu, X Zhou, Y Liu, S Tan, Y Li - Frontiers in immunology, 2021 - frontiersin.org
Systemic lupus erythematosus (SLE) is a potentially fatal multisystem inflammatory chronic
disorder, the etiology and pathogenesis of which remain unclear. The loss of immune …

Molecular mechanisms of cell death in bronchopulmonary dysplasia

X Deng, Z Bao, X Yang, Y Mei, Q Zhou, A Chen, R Yu… - Apoptosis, 2023 - Springer
Bronchopulmonary dysplasia (BPD) in neonates is the most common pulmonary disease
that causes neonatal mortality, has complex pathogenesis, and lacks effective treatment. It is …

Role of the SENP1–SIRT1 pathway in hyperoxia-induced alveolar epithelial cell injury

W Dong, X Zhu, X Liu, X Zhao, X Lei, L Kang… - Free Radical Biology and …, 2021 - Elsevier
Bronchopulmonary dysplasia (BPD) is a common complication in preterm infants, and its
main pathogenesis partly involves oxidative stress. A large number of studies have shown …

[HTML][HTML] SIRT1-related signaling pathways and their association with bronchopulmonary dysplasia

K Yang, W Dong - Frontiers in Medicine, 2021 - frontiersin.org
Bronchopulmonary dysplasia (BPD) is a chronic and debilitating disease that can exert
serious and overwhelming effects on the physical and mental health of premature infants …

Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for bronchopulmonary dysplasia prevention in premature infants with …

W Tang, S Chen, D Shi, T Ai, L Zhang… - Pediatric …, 2022 - Wiley Online Library
Objective To address the effectiveness and safety of early airway combined utilization of
budesonide and surfactant for bronchopulmonary dysplasia (BPD) prevention in premature …

[HTML][HTML] Astragaloside IV alleviates heart failure by regulating SUMO‑specific protease 1 Corrigendum in/10.3892/etm. 2023.12021

J Liu, Y Li, X Bian, N Xue, J Yu… - Experimental and …, 2021 - spandidos-publications.com
The present study investigated whether the protective effect and mechanism of
astragaloside IV (AS‑IV) on heart failure (HF) involves small ubiquitin‑like modifier (SUMO) …

Long-term Effects of Intratracheal Budesonide and Surfactant for the Prevention of Bronchopulmonary Dysplasia: A Narrative Review

S Nobile, CDS Morgia, M Hall - American Journal of …, 2024 - thieme-connect.com
Objective This study aimed to compare the safety and efficacy of intratracheal administration
of budesonide and surfactant with surfactant alone for bronchopulmonary dysplasia (BPD) …

Aryl hydrocarbon receptor (AhR) is regulated by hyperoxia in premature infants

X Yang, X Wang, W Dong - The Journal of Maternal-Fetal & …, 2024 - Taylor & Francis
Objective To investigate whether aryl hydrocarbon receptor (AhR) is involved in hyperoxia-
mediated oxidative stress by observing the relationship between AhR and reactive oxygen …

Efficacy and safety of different inhaled corticosteroids for bronchopulmonary dysplasia prevention in preterm infants: a systematic review and meta-analysis

M Zhang, W Zhang, H Liao - Respiratory Medicine and Research, 2024 - Elsevier
Background This systematic review and meta-analysis aimed to evaluate the efficacy and
safety of inhaled corticosteroids (budesonide, beclomethasone, or fluticasone propionate) in …